Jinming Yu
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 35
- Cancer Immunotherapy and Biomarkers 17
- Lung Cancer Research Studies 14
- Inflammatory Biomarkers in Disease Prognosis 6
-
- Cancer, Hypoxia, and Metabolism 6
Jinming Yu
56 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 1.2k
- Cancer Research 456
- Immunology 501
- Pulmonary and Respiratory Medicine 671
- Hepatology 87
Countries citing papers authored by Jinming Yu
This map shows the geographic impact of Jinming Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinming Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinming Yu more than expected).
Fields of papers citing papers by Jinming Yu
This network shows the impact of papers produced by Jinming Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinming Yu. The network helps show where Jinming Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinming Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 13 | |
| 10 | 2024 | 6 | |
| 11 | 2023 | 20 | |
| 12 | 2020 | 2 | |
| 13 | 2017 | 189 | |
| 14 | [Standards for the diagnosis and treatment of primary lung cancer (2015 version) in China]. | 2015 | 37 |
| 15 | 2012 | 56 | |
| 16 | 2011 | 14 | |
| 17 | An Analysis on Role of FDG PET in Assessment of Staging for 26 Cases with Nasopharyngeal Carcinoma | 2007 | 1 |
| 18 | Advance of breast cancer resistance protein | 2006 | 2 |
| 19 | Value of CT on defining the gross tumor volume of non-small cell lung cancer | 2004 | 1 |
| 20 | 1997 | 19 |
About Jinming Yu
Jinming Yu is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Radiology, Nuclear Medicine and Imaging, having authored 66 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Lung Cancer Research Studies (14 papers), Lung Cancer Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Esophageal Cancer Research and Treatment (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (456 citations), Immunology (501 citations), Pulmonary and Respiratory Medicine (671 citations) and Hepatology (87 citations). Jinming Yu has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Feifei Teng, Xiangjiao Meng, Dawei Chen, Zengfu Zhang, Xu Liu, Ligang Xing, Zhaoqin Huang, Fang Shi, Li Kong and Hui Zhu. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Cancer Letters, Future Oncology and BMC Endocrine Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.